0 81

Cited 1 times in

The LAW index as an accurate indicator of the initiation of antiviral treatment in patients with chronic hepatitis B

Authors
 Jae Min Lee  ;  Yeon Seok Seo  ;  Tae Hyung Kim  ;  Jem Ma Ahn  ;  Sun Young Yim  ;  Seung Up Kim  ;  Young Kul Jung  ;  Ji Hoon Kim  ;  Hyunggin An  ;  Hyung Joon Yim  ;  Jong Eun Yeon  ;  Hong Sik Lee  ;  Kwan Soo Byun  ;  Soon Ho Um  ;  Chang Duck Kim  ;  Ho Sang Ryu 
Citation
 Journal of Gastroenterology and Hepatology, Vol.32(1) : 208-214, 2017 
Journal Title
 Journal of Gastroenterology and Hepatology 
ISSN
 0815-9319 
Issue Date
2017
MeSH
Adult ; Antiviral Agents/administration & dosage* ; Biomarkers* ; Drug Administration Schedule* ; Female ; Fibrosis ; Hepatitis B, Chronic/drug therapy* ; Hepatitis B, Chronic/pathology* ; Humans ; Liver/pathology* ; Male ; Middle Aged ; Multivariate Analysis ; Necrosis ; Predictive Value of Tests ; ROC Curve ; Regression Analysis ; Severity of Illness Index
Keywords
APRI ; antiviral treatment ; chronic hepatitis B ; index ; liver stiffness measurement
Abstract
BACKGROUND AND AIM: Considering that inflammation and fibrosis are major factors for the indication of antiviral treatment, liver stiffness measurements could help identify patients who require antiviral treatment. This study evaluated factors that best identify patients who require antiviral treatment and to develop a new indicator for chronic hepatitis B (CHB). METHODS: Patients with CHB were randomly classified into a training or validation group, and a model for predicting necroinflammatory activity ≥ A3 or fibrosis grade ≥ F2 (A3F2) was established in the training group using binary regression analysis and validated in the validation group. Predictive efficacy was compared using area under the receiver-operating characteristics curve analysis. RESULTS: Four-hundred ninety-two patients were enrolled. In the training group, female sex, aspartate aminotransferase-to-platelet count ratio index (APRI), and liver stiffness were independent predictors of A3F2 on multivariate analysis. These variables were used to construct a novel model, called the LAW (liver stiffness, APRI, woman) index, as follows: 1.5 × liver stiffness value (kPa) + 3.9 × APRI + 3.2 if female. The LAW index was a better predictor of A3F2 than the APRI or liver stiffness measurement in both training group (0.870; 95% confidence interval, 0.822-0.910) and validation group (0.862; 95% confidence interval, 0.813-0.903). CONCLUSIONS: The LAW index was able to accurately identify patients with CHB who required antiviral treatment. A LAW index of >10.1 could be a strong indicator for the initiation of antiviral treatment in patients with CHB.
Full Text
http://onlinelibrary.wiley.com/doi/10.1111/jgh.13447/abstract
DOI
10.1111/jgh.13447
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Kim, Seung Up(김승업) ORCID logo https://orcid.org/0000-0002-9658-8050
Export
RIS (EndNote)
XLS (Excel)
XML
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/154461
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse